Latest Paclitaxel Stories
- Patent Covers Taxane Prodrug Nanoparticle Delivery Technology - EWING, N.J., Dec. 18, 2014 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
CYRAMZA is the first treatment approved in the U.S. for use in combination with docetaxel in second-line metastatic non-small cell lung cancer INDIANAPOLIS, Dec.
HARBIN, China, Dec. 16, 2014 /PRNewswire/ -- Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: YEWB), today announced that it is entering into the U.S.
SAN ANTONIO, December 11, 2014 /PRNewswire/ -- - The first study in the world combining Reparixin, an oral inhibitor of CXCR1/2, with standard
SAN DIEGO, Dec. 3, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
LAUSANNE, Switzerland, November 18, 2014 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs
SAN DIEGO, Nov. 12, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), today announced that Dr.
CYRAMZA now approved both as a single-agent treatment and in combination with chemotherapy INDIANAPOLIS, Nov.
Study Failed to Meet Secondary Endpoint of Overall Survival THOUSAND OAKS, Calif., Nov.
- ABRAXANE plus gemcitabine to be PBS listed for Australian patients with metastatic pancreatic cancer from 1 November MELBOURNE, Australia, Oct.
- To give a box on the ear to.